VTVT vTv Therapeutics Inc

Price (delayed)

$30.58

Market cap

$120.91M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.59

Enterprise value

$34.27M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 44

vTv Therapeutics Inc. is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv's clinical pipeline is led by cadisegliatin, a potential adjunctive therapy to insulin for ...

Highlights
VTVT's debt has dropped by 100% year-on-year
The net income has surged by 76% year-on-year
The quick ratio has soared by 152% YoY but it has decreased by 13% from the previous quarter
The company's EPS has surged by 81% YoY but it fell by 28% QoQ
VTVT's equity is down by 13% since the previous quarter

Key stats

What are the main financial stats of VTVT

VTVT stock price

How has the vTv Therapeutics stock price performed over time
Intraday
-1.67%
1 week
0.39%
1 month
-8.04%
1 year
39%
YTD
-23.53%
QTD
-18.78%

Financial performance

How have vTv Therapeutics's revenue and profit performed over time
Revenue
$36.84M
Gross profit
$36.84M
Operating income
-$9.19M
Net income
-$4.76M
Gross margin
100%
Net margin
-12.9%
VTVT's net margin has surged by 100% year-on-year
The operating margin has soared by 100% YoY
The net income has surged by 76% year-on-year
VTVT's operating income has soared by 64% YoY

Price vs fundamentals

How does VTVT's price correlate with its fundamentals

Growth

What is vTv Therapeutics's growth rate over time

Valuation

What is vTv Therapeutics stock price valuation
P/E
N/A
P/B
1.53
P/S
10.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.93
The company's EPS has surged by 81% YoY but it fell by 28% QoQ
VTVT's price to book (P/B) is 13% lower than its last 4 quarters average of 1.8
VTVT's equity is down by 13% since the previous quarter
The P/S is 99% lower than the 5-year quarterly average of 2007.2

Efficiency

How efficient is vTv Therapeutics business performance
The company's return on sales has surged by 100% YoY
vTv Therapeutics's return on equity has surged by 97% YoY
vTv Therapeutics's return on assets has surged by 91% YoY

Dividends

What is VTVT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VTVT.

Financial health

How did vTv Therapeutics financials performed over time
The quick ratio has soared by 152% YoY but it has decreased by 13% from the previous quarter
The current ratio has soared by 151% year-on-year but it is down by 13% since the previous quarter
VTVT's debt is 100% smaller than its equity
VTVT's debt has dropped by 100% year-on-year
The debt to equity has dropped by 100% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.